AACR Releases Inaugural Pediatric Cancer Progress Report
More than 30 new drugs have been approved for pediatric cancer in the past 10 years, but progress has...
Search/Filter
Loading...
AACR Applauds Selection of Richard Pazdur, MD, as Director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Richard Pazdur, MD, on his appointment as Director...
AACR Congratulates Members Elected to the National Academy of Medicine
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its sincerest congratulations to the nine AACR members who...
AACR Applauds Appointment of Anthony G. Letai, MD, PhD, as Director of the National Cancer Institute
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Anthony G. Letai, MD, PhD, on his appointment...
New Survey Finds Overwhelming Public Support for Federal Funding for Medical and Cancer Research
89% of voters support the federal government using taxpayer dollars to fund medical research 83% of respondents favor increasing...
AACR Cancer Progress Report Highlights Lifesaving Impact of Federal Investments in Cancer Research
FDA approved 20 new cancer drugs during the 12 months covered by the report, but challenges such as early-onset...
AACR Statement on Biden’s Cancer Diagnosis
PHILADELPHIA – The American Association for Cancer Research (AACR) today issued the following statement regarding former President Joseph R....
William Hait, MD, PhD, FAACR, Named Chief Scientific Advisor for the American Association for Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of William N. Hait, MD, PhD,...
Keith T. Flaherty, MD, FAACR, Elected as American Association for Cancer Research President-Elect for 2025-2026
New Treasurer and five new Board of Directors members elected PHILADELPHIA – The members of the American Association for...
AACR Statement and Call to Action Regarding the Administration’s Recent Actions Affecting NIH and the American People
The American Association for Cancer Research (AACR) is deeply concerned that the Administration’s recent actions are threatening the National...